MDLN Medline Inc.
USHealthcareAs of 2026-07-10 16:00
Why MDLN matters now
Medline Inc. (MDLN) is a US stock in Healthcare. The latest InvestLog snapshot shows $41.04 with +0.47% on the session and $34.70B in market capitalization; recent performance reads 1-month -4.67% and YTD -14.43%.
The latest financial table shown here is Q1 2026, with revenue of $7.35B, net income of $129.0M, and EPS of $0.16. Investors can compare that operating picture with valuation signals such as P/E 30.25 and FCF yield 5.0%.
The latest indexable market news headline is "INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Medline Industries, Inc. - MDLN" from PRNewsWire.
Additional event context on this page matters because analyst consensus is Buy with a median target of $48.00; recent insider activity includes BCP 8 Holdings Mozart Manager L.L.C. filing S-Sale. These signals are research inputs, not a recommendation.
Valuation
P/E (TTM)
30.25
PEG
—
P/B
2.61
P/S
1.04
EV/EBITDA
14.94
DCF Value
$75.30
FCF Yield
5.0%
Div Yield
0.0%
Margins & Returns
Gross Margin
24.0%
Operating Margin
7.0%
Net Margin
3.3%
ROE
6.9%
ROA
2.5%
ROIC
5.0%
Financials
| Period | Revenue | Net Income | EPS |
|---|---|---|---|
| Q1 2026 | $7.35B | $129.0M | $0.16 |
| Q4 2025 | $7.79B | $180.0M | $0.22 |
| FY 2025 | $28.43B | $1.16B | $1.43 |
| Q3 2025 | $7.12B | $322.0M | $0.41 |
Analyst Ratings
Consensus
Buy
Target (Consensus)
$48.55
Target (Median)
$48.00
Target Range
$38.00 - $60.00
Trading Activity
Insider Trades
Related Stocks
Latest News
Company Info
Sector
Healthcare
Industry
Medical - Instruments & Supplies
Country
US
Exchange
—
Beta
-0.24
Medline Inc. is a global manufacturer of medical and surgical products, catering to a broad spectrum of healthcare providers. Their clientele includes hospitals, surgical centers, physician practices, post-acute care facilities, and nursing homes, both domestically and worldwide. The company's operations are divided into two primary divisions: the Medline Brand and Supply Chain Solutions. The Medline Brand division focuses on the production and sourcing of its proprietary medical products, categorized into three key areas: Within Frontline Care, Medline provides a wide array of patient-facing medical and surgical items. This encompasses essentials like wound care treatments, examination gloves, skin and incontinence products, sanitation supplies, various textiles, hand sanitizers, durable medical equipment (DME), patient-specific plastic goods, and decolonization and infection control solutions. The Surgical Solutions category delivers comprehensive product lines for operating rooms and perioperative settings. Offerings range from surgical procedure trays, drapes, and gowns to personal protective equipment (PPE), sterile wraps, various surgical instruments, specialized surgeon's gloves, complete procedure kits, and orthopedic implants. Finally, Laboratory and Diagnostics supplies critical solutions for clinical testing and analysis. This includes point-of-care testing devices, analytical instruments, laboratory consumables, advanced diagnostic equipment, vital signs monitoring systems, and products for anatomic pathology and phlebotomy. The Supply Chain Solutions segment is responsible for sourcing and distributing a diverse portfolio of third-party products, including those from well-known national brands. Beyond distribution, this segment offers comprehensive logistics and supply chain optimization services to clients both domestically and internationally. These optimization services encompass strategic consulting, outsourced management of warehousing and technology, specialized "put-away-ready" packaging, third-party logistics (3PL), inventory rationalization strategies, and efficient route planning. Established in 1966, Medline Inc. maintains its headquarters in Northfield, Illinois.